✨ Medicines Consent Notices




4648 NEW ZEALAND GAZETTE No. 196

Schedule

Name and Strength Form Name and Address of Manufacturer Proprietary Name (if any)
Factor II 500 IU, factor IX 500 IU, factor X 500 IU with water for injection 20 mL as diluent Injection, powder with diluent CSL Limited, Bioplasma Division, Broadmeadows, Victoria, Australia. Diluent: Pharmacia & Upjohn (Perth) Pty Limited, Bentley, Western Australia, Australia Prothrombinex-HT

Note: This consent is valid for 2 years from the date of publication of this notice.

Dated this 26th day of November 1998.

G. R. BOYD,
Chief Advisor, Regulation and Safety, pursuant to delegation given by the Minister of Health on the 20th day of February 1997.

g08566

Consent to the Distribution of Changed Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act and are set out in the Schedule hereto:

Schedule

Name and Strength Form Name and Address of Manufacturer Proprietary Name (if any)
Mesalazine 1% w/v, 4% w/v Enema Tillotts Pharma AG., Ziefen, Switzerland Asacol Enema
Metoprolol succinate 47.5 mg, 95 mg, 190 mg Tablets, modified release Astra Pharmaceutical Production AB., SΓΆdertΓ€lje, Sweden Betaloc CR
Bromhexine hydrochloride 1.6 mg/mL Solution, oral Boehringer Ingelheim Pharma KG., Biberach an der Riss, Germany and Boehringer Ingelheim France, Reims Cedex, France Bisolvon Elixir
Alendronate sodium 13.05 mg, 52.21 mg equivalent to 10 mg, 40 mg alendronic acid Tablets Merck Manufacturing Division, Bo. Sabana Hoyos, Arecibo, Puerto Rico and Merck Sharp & Dohme Italia SpA., Pavia, Italy Fosamax
Ispaghula husk 5.25 mg/dose Granules, oral Reckitt & Colman Products Limited, Hull, North Humberside, United Kingdom Fybogest Forte Orange, Fybogest Forte Regular
Ispaghula husk 5.25 mg/dose Granules, oral Reckitt & Colman Products Limited, Hull, North Humberside, United Kingdom Fybogest Orange, Fybogest Regular
Ispaghula husk 3.5 mg/dose Granules, oral Reckitt & Colman Products Limited, Hull, North Humberside, United Kingdom Fybogest Regular
Somatropin 0.2 mg, 0.4 mg, 0.6 mg, 0.8 mg, 1 mg, 1.2 mg, 1.4 mg, 1.6 mg, 1.8 mg, 2 mg Injection with diluent Vetter Pharma-Fertigung GmbH & Co Kg., Ravensburg, Germany and Recip AB., Stockholm, Sweden Genotropin Miniquick
Midazolam hydrochloride 1 mg/mL, 5 mg/mL Injection, solution F Hoffmann-La Roche Limited, Basle, Switzerland Hypnovel
Caldiamide sodium 12 mg/mL, gadodiamide 287 mg/mL Injection, solution Nycomed AS Production, Oslo, Norway; Nycomed Puerto Rico Inc., Barceloneta, Puerto Rico and Nycomed Ireland Limited, Carrigtwohill, County Cork, Eire Omniscan
Pantoprazole sodium sesquihydrate 22.6 mg, 45.1 mg equivalent to 20 mg, 40 mg pantoprazole Tablets, enteric coated Byk Gulden Lomberg Chemische Fabrik GmbH., Konstanz, Germany and Oranienburger Pharmawerk GmbH., Oranienburg, Germany Somac
Ondansetron 4 mg, 8 mg Wafer Scherer DDS Limited, Blagrove, Swindon, Wiltshire, England Zofran Zydis
Goserelin acetate 3.6 mg Implant, subcutaneous Zeneca Pharmaceuticals, Macclesfield, Cheshire, England Zoladex Injectable Implant

Dated this 26th day of November 1998.

G. R. BOYD,
Chief Advisor, Regulation and Safety, pursuant to delegation given by the Minister of Health on the 20th day of February 1997.

g08567

Consent to the Distribution of Changed Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act and are set out in the Schedule hereto:



Next Page →

PDF embedding disabled (Crown copyright)

View this page online at:


VUW Te Waharoa PDF NZ Gazette 1998, No 196


NZLII PDF NZ Gazette 1998, No 196





✨ LLM interpretation of page content

πŸ₯ Provisional Consent to the Distribution of a New Medicine (continued from previous page)

πŸ₯ Health & Social Welfare
26 November 1998
Medicines Act 1981, Provisional Consent, Factor II, Factor IX, Factor X
  • G. R. Boyd, Chief Advisor, Regulation and Safety

πŸ₯ Consent to the Distribution of Changed Medicines

πŸ₯ Health & Social Welfare
26 November 1998
Medicines Act 1981, Consent, Mesalazine, Metoprolol succinate, Bromhexine hydrochloride, Alendronate sodium, Ispaghula husk, Somatropin, Midazolam hydrochloride, Caldiamide sodium, Pantoprazole sodium sesquihydrate, Ondansetron, Goserelin acetate
  • G. R. Boyd, Chief Advisor, Regulation and Safety

πŸ₯ Consent to the Distribution of Changed Medicines

πŸ₯ Health & Social Welfare
26 November 1998
Medicines Act 1981, Consent, Changed Medicines
  • G. R. Boyd, Chief Advisor, Regulation and Safety